SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 195.83-0.7%Dec 26 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (24426)8/12/1998 10:05:00 PM
From: Machaon  Read Replies (2) of 32384
 
The negotiations between Lilly, Seragen and Ligand started way back in April 1997! That's a little bit of a surprise. It sounds like Ligand really thought that Seragen's science was worth going after.

The stockholder's filing the suit wanted Seragen to hold out for a higher purchase price, IMHO.

I wonder how much was spent developing Seragen's Fusion Proteins?

I guess the next step would be to look at Seragen's pipeline and see just what comes with ONTAK.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext